Bacterial urinary mutagenicity test for monitoring of exposure to genotoxic compounds: A review

Central European Journal of Public Health

Volumn 10, Issue 3, 2002, Pages 124-129

  Černá, Milena ^a   Pastorkova A ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

Biomarker of exposure to genotoxins; Salmonella microsome mutagenicity assay; Urinary mutagenicity

Indexed keywords

BIOLOGICAL MARKER; MUTAGENIC AGENT;

AMES TEST; BACTERIUM; BIOLOGICAL MONITORING; DIET; ENVIRONMENTAL EXPOSURE; EXPOSURE; GENETIC POLYMORPHISM; GENOTOXICITY; HUMAN; METHODOLOGY; MUTAGEN TESTING; REVIEW; SALMONELLA TYPHIMURIUM; SMOKING; URINALYSIS; URINARY TRACT;

CONFOUNDING FACTORS (EPIDEMIOLOGY); ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HUMANS; MUTAGENICITY TESTS; MUTAGENS; SALMONELLA TYPHIMURIUM; URINALYSIS;

EID: 0036734324     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Cyclophosphamide Pilot study of genetically active metabolites in the urine of a treated human patients. Induction of mitotic gene conversion in yeast
2. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome test
3. Detection of occupational and environmental exposures by bacterial mutagenesis assays of human body fluids
4. Bacterial urinary assay in monitoring exposure to mutagens and carcinogens
5. Mutagenicity in urine of nurses handling cytostatic drugs
6. Mutagenicity of urine from nurses handling cytostatic drugs, influence of smoking
7. Occupational risk of cytostatics
8. Monitoring exposure of nursing and pharmacy personel to cytostatic drugs: Urinary mutagenicity assays and urinary platinum as markers of absorption
9. Occupational exposure to anticancer drugs. Potential and real hazards
10. Chromosomal aberrations. SCE and urine mutagenicity in workers occupationally exposed to cytostatic drugs
11. Effect of ascorbic acid prophylaxis on the frequency of chromosome aberrations, urine mutagenicity and nucleolus test in workers occupationally exposed to cytostatic drugs
12. Urinary biological monitoring markers of anticancer drug exposure in oncology nurses
13. Chromosomal aberrations in peripheral lymphocytes of nurses and physicians handling antineoplastic drugs
14. Urinary cyclophosphamide excretion and chromosomal aberrations in peripheral blood lymphocytes after occupational exposure to antineoplastic agents
15. Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: Urinary excretion and cytogenetic studies
16. Biological and environmental monitoring of occupational exposure to cyclophosphamide in industry and hospitals
17. The risk at work during the application of cytostatics
18. Detection of occupational exposure to genotoxic agents with a urinary mutagen assay
19. Determinants of urinary thioethers, D-glucaric acid and mutagenicity after exposure to polycyclic aromatic hydrocarbons assessed by air monitoring and measurement of 1-hydroxypyrene in urine: A cross-sectional study in workers of coke and graphite-electrode-producing plants
20. Exposure of coke-oven workers to polycyclic aromatic hydrocarbons based on biological monitoring results
21. Urine mutagenicity of steel workers exposed to coke oven emissions
22. Mutagenic activity of the urine of workers employed in the processing of coal tar
23. Urinary mutagenicity in occupational exposure to mineral oils and iron particles
24. Mutagenicity studies and D-glucaric acid determination in urine of workers exposed to mineral oils
25. Mutagens in urine of carbon electrode worker
26. Genetic monitoring of aluminium workers exposed to coal tar pitch volatiles
27. Urinary and faecal mutagenicity in car mechanics exposed to diesel exhaust and in unexposed office workers
28. Detection of mutagenic activity in the urines of anestesiologists: A preliminary report
29. Mutagenicity in urine of workers in rubber industry
30. Urinary mutagens in municipal sewage workers and water treatment workers
31. Mutagenicity of urine from greenhouse workers
32. Mutagens in urine sampled repetitively from municipal refuse incinerator workers and water treatment workers
33. Urinary screening for potentially genotoxic exposures in a chemical industry
34. Monitoring of carcinogenic risks in tannery workers by means of desquamative lung and bladder cytology and urinary mutagenicity
35. Biological effects in a chemical factory with mutagenic exposure. III. Urinary mutagenicity and thioether excretion
36. Urinary mutagens in cosmetologists and dental personnel
37. Urinary mutagenicity as an indicator of occupational exposure in a cohort of cosmetologists
38. A simple modification of the Salmonella liquid-incubation assay. Increased sensitivity for detecting mutagens in human urine
39. Urinary mutagenic activity in workers exposed to diesel exhaust
40. The use of a urine mutagenicity assay in the monitoring of environmental exposure to genotoxins
41. A molecular epidemiology study in women from Upper Silesia, Poland
42. Concentrations of mutagens from urine by adsorption with the nonpolar resin XAD-2: Cigarette smokers have mutagenic urine
43. Isolation of frameshift mutagens from smoker's urine: Experiences with three concentration methods
44. Urinary mutagen levels in smokers
45. Mutagens in human urine: Effects of cigarette smoking and diet
46. Sensitivity of Salmonella typhimurium YG1024 to urine mutagenicity caused by cigarette smoking
47. Use of Salmonella typhimurium TA98, YG1024 and YG1021 and deconjugating enzymes for evaluating the mutagenicity from smokers' urine
48. Excretion of mutagens in human urine after passive smoking
49. Urinary mutagenicity in nonsmokers following exposure to fresh diluted sidestream cigarette smoke
50. Mutagenicity studies in a tyre plant: In vitro activity of workers' urinary concentrates and raw materials
51. Testing for mutagens in an aluminium plant. The results of Salmonella typhimurium tests on urine from exposed workers
52. Mutagenicity study of urine from smoking and non-smoking road tanker drivers
53. Mutagens carcinogens, and tumor promoters in our daily foods
54. Detection of mutagenic activity in human urine following fried pork or bacon meals
55. Urinary mutagens in humans after fried pork and bacon meals
56. Dietary factors affecting the urinary mutagenicity assay system. I. Detection of mutagenic activity in human urine following a fried beef meal
57. Mutagenicity of human urine after the consumption of fried salted salmon
58. Ingestion of parsley inhibits the mutagenicity of male human urine following consumption of fried salmon
59. Pilot study and conjugated urinary mutagenicity during consumption of pan-fried meats: Possible modulation by cruciferous vegetables, glutatione S-transferase-M1, and N-acetyltransferase-2
60. Smokers and urinary genotoxins: Implications for selection of cohorts and modulation of endpoints in chemoprevention trials
61. Mutagenesis assays on urines produced by patients administered adriamycin and cyclophosphamide
62. Detection of mutagenic activity of metronidazole and niridazole in body fluids of humans and mice
63. Use of an analysis of mutagenic activity of body fluids in the first stage of clinical testing of drugs
64. Genotoxicity and carcinogenicity of metronidazole
65. Mutagenicity for Salmonella typhimurium of urine obtained from humans receiving nitrofurantoin
66. Mutagenicity studies with nitrofurans. III. Mutagenicity testing of nitrofurylacrylic acid in human blood and urine
67. Modulation of urinary mutagenicity by genetically determined metabolism in smokers
68. GSTM1 and NAT2 genotypes and urinary mutagens in coke oven workers
69. Biomarker studies in Northern Bohemia
70. Influence of metabolic genotype GSTM1 on levels of urinary mutagens in patients treated topically with coal tar
71. Urinary mutagenicity on TA98 and YG1024 Salmonella typhimurium strains after a hamburger meal: Influence of GSTM1 and NAT2 genotypes
72. Application of urinary mutagen testing to detect workplace hazardous exposure and bladder cancer
73. Adsorption of mutagens to cotton bearing covalently bound trisulfo-copper-phthalocyanine
74. The identification and characterization of a urinary mutagen resulting from cigarette smoke
75. Sensitivity of different bacterial assays in detecting mutagens in urine of humans exposed to polycyclic aromatic hydrocarbons
76. Mutagenicity of β-glucuronidase in the Ames test
77. Reproducibility of microbial mutagenicity assays. II. Testing of carcinogens and noncarcinogens in Salmonella typhimurium and Escherichia coli
78. Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals
79. Gene Tox manager for bacterial mutagenicity assays: A personal computer and mini computer system
80. Statistical methods for the Ames Salmonella assay: A review